A5006992781- COVID-19 epidemiological studies
- SARS-CoV-2 and COVID-19 Research
- Respiratory viral infections research
- Viral Infections and Outbreaks Research
- Influenza Virus Research Studies
- Vaccine Coverage and Hesitancy
- SARS-CoV-2 detection and testing
- Viral gastroenteritis research and epidemiology
- COVID-19 and Mental Health
- Pain Management and Opioid Use
- Data-Driven Disease Surveillance
- Opioid Use Disorder Treatment
- COVID-19 Pandemic Impacts
- Pharmaceutical Practices and Patient Outcomes
Inserm
2020-2023
Sorbonne Université
2020-2023
Institut Pierre Louis d‘Épidémiologie et de Santé Publique
2020-2023
European countries are focusing on testing, isolation, and boosting strategies to counter the 2022/2023 winter surge due SARS-CoV-2 Omicron subvariants. However, widespread pandemic fatigue limited compliance potentially undermine mitigation efforts.To establish a baseline for interventions, we ran multicountry survey assess respondents' willingness receive booster vaccination comply with testing isolation mandates. Integrating estimated immunity data in branching process epidemic spreading...
Abstract Since the start of COVID-19 pandemic, French health authorities have encouraged barrier measures and implemented three lockdowns to slow SARS-CoV-2 transmission. We aimed examine impact these on epidemiology acute gastroenteritis (AGE) in France, from November 2019 August 2021. describe trends AGE indicators syndromic surveillance a sentinel network. Additionally, we reported illness data community based cohort, frequencies adherence repeated quantitative surveys. From week 7 2020,...
Abstract European countries are focusing on testing, isolation, and boosting strategies to counter the 2022/2023 winter surge due Omicron subvariants. However, widespread pandemic fatigue limited compliance potentially undermine mitigation efforts. To establish a baseline for interventions, we ran multicountry survey assess respondents’ willingness receive booster vaccination comply with testing isolation mandates. The vast majority of participants (N=4,594) was willing adhere (>91%)...
ABSTRACT A novel testing policy was implemented in May France to systematically screen potential COVID-19 infections and suppress local outbreaks while lifting lockdown restrictions. 20,736 virologically-confirmed cases were reported mainland from 13, 2020 (week 20, end of lockdown) June 28 26). Accounting for missing data the delay symptom onset confirmation test, this corresponds 7,258 [95% CI 7,160-7,336] with during period, a likely underestimation real number. Using age-stratified...
Abstract Background In Europe and France, the use of opioid analgesic drugs has become widespread as an option for pain management. However, their can lead to nonmedical and/or disorder (OUD). This work aimed assess perceived risk OUD secondary by general population. Methods We conducted a cross‐sectional observational study using GrippeNet web‐based cohort, comprising about 10,000 French volunteers from population, self‐administered questionnaire. The main outcome was use, assessed 4‐item...
Vaccination of the at-risk population against influenza by pharmacists was widely implemented in France 2019. Only little data are available about using this service. We have explored characteristics and determinants vaccinated pharmacy through a web-based cohort during 2019-20 winter season. This study is based on profile survey over-18 participants GrippeNet.fr, for Population were described inclusion questionnaire data. Factors associated with vaccination analysed logistic regression...